Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Tischkowitz

Showing results (151-160 of 258) with videos related to

Pageof 26
Sort By:
JAMA|January 6, 2011
DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumorsThomas Rio Frio, Amin Bahubeshi, Chryssa Kanellopoulou, et al.
European Urology|December 3, 2014
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate CancerElena Castro, Chee Goh, Daniel Leongamornlert, et al.
NPJ Breast Cancer|June 25, 2026
Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriersMartin Widschwendter, Rita Schmutzler, Nora Pashayan, et al.
Journal of the National Cancer Institute|March 3, 2020
Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast CancerAnne S Reiner, Mark E Robson, Lene Mellemkjær, et al.
British Journal of Cancer|July 17, 2025
Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK populationLorenzo Ficorella, Xin Yang, Nasim Mavaddat, et al.
JAMA Network Open|September 28, 2019
Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast CancerGordon P Watt, Anne S Reiner, Susan A Smith, et al.
The Lancet. Gastroenterology & Hepatology|May 1, 2018
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing studyEleanor Fewings, Alexey Larionov, James Redman, et al.
Endoscopy|June 12, 2025
Clinical decision tree for optimising endoscopic assessment of signet ring cell carcinoma in hereditary diffuse gastric cancer surveillanceLianlian Wu, Judith Honing, Anjui Wu, et al.
Cancer Research|August 1, 2022
Germline Missense Variants in CDC20 Result in Aberrant Mitotic Progression and Familial CancerOwen J Chen, Ester Castellsagué, Mohamed Moustafa-Kamal, et al.
BJU International|May 27, 2018
Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutationsElizabeth K Bancroft, Sibel Saya, Elizabeth C Page, et al.
Pageof 26

Showing results (151-160 of 258) with videos related to

Sort By:
Pageof 26
JAMA|January 6, 2011
DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumorsThomas Rio Frio, Amin Bahubeshi, Chryssa Kanellopoulou, et al.
European Urology|December 3, 2014
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate CancerElena Castro, Chee Goh, Daniel Leongamornlert, et al.
NPJ Breast Cancer|June 25, 2026
Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriersMartin Widschwendter, Rita Schmutzler, Nora Pashayan, et al.
Journal of the National Cancer Institute|March 3, 2020
Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast CancerAnne S Reiner, Mark E Robson, Lene Mellemkjær, et al.
British Journal of Cancer|July 17, 2025
Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK populationLorenzo Ficorella, Xin Yang, Nasim Mavaddat, et al.
JAMA Network Open|September 28, 2019
Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast CancerGordon P Watt, Anne S Reiner, Susan A Smith, et al.
The Lancet. Gastroenterology & Hepatology|May 1, 2018
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing studyEleanor Fewings, Alexey Larionov, James Redman, et al.
Endoscopy|June 12, 2025
Clinical decision tree for optimising endoscopic assessment of signet ring cell carcinoma in hereditary diffuse gastric cancer surveillanceLianlian Wu, Judith Honing, Anjui Wu, et al.
Cancer Research|August 1, 2022
Germline Missense Variants in CDC20 Result in Aberrant Mitotic Progression and Familial CancerOwen J Chen, Ester Castellsagué, Mohamed Moustafa-Kamal, et al.
BJU International|May 27, 2018
Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutationsElizabeth K Bancroft, Sibel Saya, Elizabeth C Page, et al.
Pageof 26